TLS-MVI integration optimizes HCC risk stratification and therapeutic decisions.
0/5 보강
APA
Hou W (2026). TLS-MVI integration optimizes HCC risk stratification and therapeutic decisions.. International journal of surgery (London, England), 112(2), 5378-5379. https://doi.org/10.1097/JS9.0000000000003678
MLA
Hou W. "TLS-MVI integration optimizes HCC risk stratification and therapeutic decisions.." International journal of surgery (London, England), vol. 112, no. 2, 2026, pp. 5378-5379.
PMID
41091958
같은 제1저자의 인용 많은 논문 (5)
- HAIC-first sequential therapy for unresectable hepatocellular carcinoma.
- LncRNA FEZF1-AS1 promotes the tumorigenesis and suppresses ferroptosis in non-small cell lung cancer through the TNF-α/NF-κB pathway.
- Identification of small molecule inhibitors targeting FGFR through molecular docking-based screening.
- Optimization of ultrasound-assisted extraction of Sargassum polycystum for antitumor activity: Multi-objective optimization and mechanistic insights.
- ZNF460 inhibits HMGCL and promotes PI3K pathway in colon cancer.